000			01746nam a2200229Ia 4500
003			NULRC
005			20250520102958.0
008			250520s9999 xx 000 0 und d
020			_a9780071635004
040			_cNULRC
050			_aRM 302.5 .U54 2011
245		0	_aUnderstanding pharmacoepidemiology / _cedited by Yi Yang and Donna West-Strum
260			_aNew York : _bThe McGraw-Hill Companies, _cc2011
300			_ax, 197 pages : _billustrations ; _c23 cm.
365			_bUSD36.91
504			_aIncludes index.
505			_a1.Introduction to pharmacoepidemiology -- 2.Principles of epidemiology applied to the study 3.Study designs for pharmacoepidemiology -- 4.Using secondary data in pharmacoepidemiology -- 5.Biostatistics and pharmacoepidemiology -- 6.Other methodological issues -- 7.Evaluation of the pharmacoepidemiology literature -- 8.Medication utilization patterns -- 9.Medication safety and pharmacovigilance -- 10.The FDA perspective on postmarket drug safety.
520			_aUnderstanding Pharmacoepidemiology is a clear, engagingly written roadmap to mastering the important concepts and methods of pharmacoepidemiology. It explains what pharmacoepidemiology is, how pharmacoepidemiology studies are conducted, and how to interpret findings. You will learn the importance of pharmacoepidemiology, basic terminology used in research, and the data sources, study designs, and statistical analyses employed in pharmacoepidemiology research. Upon completing Understanding Pharmacoepidemiology you will have a better understanding of how to evaluate the associations between medication utilization and outcomes.
650			_aPHARMACOEPIDEMIOLOGY
700			_aYang, Yi;West-Strum, Donna _eeditor;editor
942			_2lcc _cBK
999			_c20432 _d20432